DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ekert H, Brizard C, Eyers R, Cochrane A, Henning R.
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
Blood Coagul Fibrinolysis 2006;
17 (05) 389-395
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.